ArticleInternal and emergency medicine2026
Progression rate of diverticular disease and associated risk factors: results from 5-year longitudinal prospective nationwide diverticular disease registry (REMAD).
Article in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural history of diverticular disease (DD) through its different subgroups (diverticulosis, symptomatic uncomplicated diverticular disease (SUDD) previous diverticulitis (PD)) is poorly defined. Few studies, mainly retrospective, have analysed its rate of progression and risk factors associated. We assessed the potential progression rate of different spectrum of DD and associated risk factors. Data from the REMAD Registry, a 5-year Italian longitudinal prospective multicentre study, were analysed. A total of 1217 patients were included that were divided into three subgroups (diverticulosis, SUDD and PD) and followed up every six months for 5 years. Amongst patients with colonic diverticulosis, about 7% progressed to SUDD with an average follow-up period of 18.3 (SD ± 16.1) months, whilst 1% had an acute episode of diverticulitis with a mean time to progression of 23.7 (SD ± 15.0) months. Amongst SUDD, 2.7% progressed to acute diverticulitis with a mean follow-up time of 29.2 (SD ± 17.1) months. Almost 20% of patients with PD had a first recurrence at a mean follow-up of 20.1 (SD ± 14.2) months, whilst 14.3% had a second recurrence at a mean follow-up of 15.6 (SD ± 7.0) months. Gender, diet (low fibre intake and meat consumption) being overweight, gastrointestinal tract medications and antiplatelet use are risk factors involved in DD progression. This longitudinal prospective study demonstrates a low progression rate in diverticulosis and SUDD, whereas diverticulitis recurrences are a frequent occurrence, representing the major clinical burden in DD. These results suggest that DD can progress, highlighting the need to understand how to prevent it from developing into a symptomatic and/or complicated form.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.